BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
批准号:
10579946
负责人:
Hamid Ghandehari
金额:
$50.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-09-28 至 2026-11-30
关键词:
AcuteAddressAdsorptionAdverse effectsAffectAnimal ModelAnimalsAntibodiesApplications GrantsBacteriaBiodistributionBiologicalBloodBone MarrowCell CycleCell divisionCessation of lifeCharacteristicsChronicCuesDependenceDoseDrug CarriersDrug Delivery SystemsExposure toFemaleFrequenciesGene ExpressionGenerationsGenesGenetic TranscriptionGeometryHealthHormonesHumanImmuneImmune responseImmune signalingImmune systemImmunoglobulin GImmunoglobulin MImmunologicsIn VitroInbred BALB C MiceInflammasomeInflammatoryInflammatory ResponseIntravenousInvestigationKnowledgeLeukocytesLiverLiver ExtractLungLymphocyteMacrophageMaximum Tolerated DoseMediatingMetabolic Clearance RateMetabolismModificationMolecularMononuclearMusOrganPhagocytesPhenotypePluripotent Bone Marrow Stem CellPorosityProliferatingPropertyProteinsRattusRecoverySafetySignal PathwaySignal TransductionSilicon DioxideSpleenSurfaceSystemTestingTimeTissuesToxic effectVariantWhole Bloodbiomaterial compatibilitycytotoxicitydensitygenotoxicitygranulocyteimmune functionimmunotoxicityin vivoinnovationintravenous administrationintravenous injectionmalemonocytenanonanoparticleneutrophiloverexpressionparticlepatient populationperipheral bloodresponsesexside effectuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
A major challenge with systemic administration of silica nanoparticles (SNPs) is clearance by and
accumulation in organs of mononuclear phagocytic system (MPS), and subsequent immune response. Poor
loading capacity of SNPs, their stability and vacuolization in macrophages, and potentially lower metabolism and
clearance rates in patient populations may necessitate administration of high and frequent doses of SNPs which
could lead to MPS saturation and overload. Detailed investigation of immunotoxicity of SNPs in the MPS is
needed to establish their safety profile to choose drug carriers with well-defined immunological properties. The
influence of SNPs on the fate and function of phagocytes after uptake and saturation, and on host immune
response need further elucidation. The correlation between the physicochemical properties of SNPs and the
mechanisms of sex-dependent toxicity is unclear. Also, the immune response alteration upon i.v. administration
of SNPs and the mechanisms behind this response are largely unknown. To address these knowledge gaps in
this grant application the following Specific Aims are proposed:
1) To investigate the influence of saturation of macrophages with SNPs on their phagocytic activity,
survival, proliferation, and immune signaling as a function of nanoparticle physicochemical properties. The
underlying hypothesis to be tested in this aim is that saturation of macrophages by SNPs will influence their
normal function, molecular signaling, and fate based on nanoparticle characteristics.
2) To investigate bone marrow toxicity and function of tissue-resident macrophages after i.v.
administration of SNPs, and assess the number and activation status of circulating phagocytes after in vitro
exposure to SNPs. The underlying hypothesis to be tested in this aim is that size, geometry, and porosity of
SNPs influence the normal function of bone marrow, tissue-resident macrophages, and peripheral blood
phagocytes, a phenomenon which may be reversible and depend on dose and frequency of administration.
3) To investigate the immune side effects and anti-PEG response of systemically administered SNPs as
a function of animal sex and particle physicochemical properties. The underlying hypotheses are: i) Anti-PEG
IgM and IgG will be generated in a time-dependent manner upon exposure to PEGylated SNPs; ii) variation in
immune response in female vs male Th1 and Th2 bias animal models will contribute to SNP toxicity and immune-
mediated side effects.
This proposal is significant because understanding key physicochemical properties of SNPs with well-
defined immunological properties will help establish safer platforms for intravenous drug delivery. It is innovative
because for the first time it approaches different SNP interactions with various components of the immune system
as a result of animal-sex and different immune-biased in a systematic fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
-
批准号:10296670
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2018
-
负责人:Hamid Ghandehari
-
依托单位:
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
-
批准号:10530585
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2018
-
负责人:Hamid Ghandehari
-
依托单位:
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
-
批准号:10058818
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2018
-
负责人:Hamid Ghandehari
-
依托单位:
In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
-
批准号:8314876
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:Hamid Ghandehari
-
依托单位:
Targeted Polymeric Combination Delivery for Treatment of Ovarian Cancer
-
批准号:7999063
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7615449
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7916398
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7627049
-
项目类别:
-
资助金额:$31.34万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7633399
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7341354
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7848308
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological Fate and Biocompatability of Dendritic and Silica-Based Nanoconstructs
-
批准号:8761265
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7487476
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
-
批准号:10357023
-
项目类别:
-
资助金额:$48.06万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological Fate and Biocompatability of Dendritic and Silica-Based Nanoconstructs
-
批准号:8918618
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7676202
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7501972
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Polymers for Targeted Delivery of Angiogenic Inhibitors
-
批准号:7142801
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2006
-
负责人:Hamid Ghandehari
-
依托单位:
Polymers for Targeted Delivery of Angiogenic Inhibitors
-
批准号:7658258
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2006
-
负责人:Hamid Ghandehari
-
依托单位:
Polymers for Targeted Delivery of Angiogenic Inhibitors
-
批准号:7434460
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2006
-
负责人:Hamid Ghandehari
-
依托单位:
海外基金